Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Personalising medicine

August 1, 2005 Research and Development

Hard times have hit the drug development industry. Faced with declining returns and the apparent waning of blockbusters, coupled with …
Feature

Iressa successor enters phase III

July 19, 2005 Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …
News

AstraZeneca invests in novel cholesterol drugs

July 15, 2005 Research and Development

AstraZeneca is investing in a range of next generation cholesterol drugs which could reverse existing vascular disease in patients.The Anglo-Swedish …
News

Lilly buys rights to novel diabetes drug

July 6, 2005 Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …
News

Bright future for new antidepressants

June 30, 2005 Research and Development, Sales and Marketing

News

FDA approves first ‘ethnic’ heart drug

June 29, 2005 Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …
News

GSK sets up new R&D centre

June 1, 2005 Research and Development

GlaxoSmithKline has set up its eighth R&D Centre of Excellence which will focus on building partnerships with biotech firms, academia …
News

Industry encouraged to invest more in pharmacy partnerships

May 27, 2005 Research and Development

Pharmaceutical companies should increase their investment in community pharmacists, according to a leading pharmacy spokesperson.Michael Holden, NHS development manager at …
News

Is your R&D team an outside bet?

May 24, 2005 Research and Development

Feature

Pfizer becomes competitive in oncology

May 24, 2005 Research and Development, Sales and Marketing

Pfizer looks set to become a serious contender in oncology with its promising phase III kidney cancer drug Sutent.Until now …
News

Smoking vaccine company seeks big pharma partner

May 17, 2005 Research and Development, Sales and Marketing

News

GSK makes strategic biotech acquisition

May 6, 2005 Research and Development, Sales and Marketing GSK, biotech

 GlaxoSmithKline will acquire a Seattle-based biotech that manufactures a key component in many of the candidates in its vaccine pipeline, …
News

Mixed news for AstraZeneca’s stroke drug Cerovive

May 4, 2005 Research and Development, Sales and Marketing

AstraZeneca has received a boost from its phase III drug Cerovive, with clinical trial data showing the treatment can reduce …
News

Labour makes clinical trials law a manifesto pledge

April 15, 2005 Research and Development

The Labour party has promised to introduce new legislation which would oblige pharmaceutical companies to publish clinical trial data for …
News

Novartis signs respiratory deal with UK biotech companies

April 14, 2005 Research and Development

Novartis has signed a deal with two UK biotech companies to develop and market a new treatment for chronic obstructive …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025